iCARE DOA 5 Panels (Configurable) Rapid Screen Test

iCARE DOA 5 Panels (Configurable) Rapid Screen Test

DOA-5 Multi-Drug Dip Test: Precision and Ease in Drug Screening

The iCARE DOA-5 Multi-Drug Dip Test represents the pinnacle of drug screening technology, offering healthcare professionals a rapid, reliable, and easy-to-use testing solution for detecting the presence of drugs and their metabolites in urine samples. This innovative test kit is particularly suitable for hospitals, with a pack size containing 20 tests, ensuring an efficient and continuous screening process.

Key Features of DOA-5 Test Kit:

  • Broad Spectrum Testing: Can detect a combination of 5 drugs from a wide range including Amphetamines, Barbiturates, Benzodiazepines, and more.
  • High Specificity and Sensitivity: Boasts a 100% specificity rate and a 90% sensitivity rate for accurate detection.
  • Rapid Results: Provides results in as little as 5 minutes, streamlining the drug screening process.
  • Storage Convenience: Designed to be stored at room temperature, simplifying inventory management.
  • Certified Quality: Meets the standards set by the CE, FDA, and has 510K clearance for most similar products.

The iCARE DOA-5 Multi-Drug Dip Test is an ideal choice for Point-of-Care Testing (POCT), given its portability and ease of use. It is especially tailored for instances where quick and reliable results are paramount.

Advanced Screening Technology

The iCARE DOA-5 Multi-Drug Dip Test employs a rapid, qualitative, competitive binding immunoassay technology. It is designed to detect configured drugs and their metabolites at or above the cutoff level of 50ng/mL, which conforms to USA, European, and International drug of abuse test standards. With its cassette dipstick format, the test allows for a clean and simple procedure, minimizing the potential for sample contamination.

Customizable Testing Options

Unique to the iCARE DOA-5 Multi-Drug Dip Test is its configurability. Facilities can choose any combination of 5 drug panels to tailor the testing to specific needs. This feature makes the iCARE DOA-5 not just a test kit but a versatile solution adaptable to various screening requirements.

Commitment to Excellence

Jal Medical demonstrates its commitment to excellence and meeting professional needs by offering private labeling options for larger orders. With a minimum order quantity of 5,000, facilities can brand the tests for their own use, reinforcing trust and recognition in their services.

The iCARE DOA-5 Multi-Drug Dip Test is more than just a drug screening kit; it’s a comprehensive solution that ensures healthcare providers can confidently and rapidly assess drug use, aiding in critical decision-making processes. With its combination of precision, speed, and user-friendliness, the iCARE DOA-5 is an invaluable asset in modern drug screening practices.